Parkinson's disease

Where the papers sit

10 papers from the last 6 months study parkinson's disease directly · updated from PubMed 12 Oct 2026

• Parkinson's Clinical Outcomes

  Clinical work is linking Parkinson's disease to acute immobilization, cardiovascular disease, mortality and prediagnostic health patterns. Akinetic collapse and sustained immobilization emerge as potentially serious outcomes requiring closer management. Claims studies examine associations such as furosemide exposure and later Parkinson's disease risk. Interpretable prediction models may integrate these comorbidities, but causal relationships remain unresolved.

  5 papers · 50%

• AI for Neurodegenerative Disorders

  AI is being applied to neurodegenerative diagnosis, co-pathology profiling, gene discovery and drug repurposing. Protein panels such as GPND-AI NULISA aim to distinguish diseases while capturing overlapping pathology. Graph representation learning links disease-associated genes to candidate treatments. Clinical trustworthiness, validation and interpretability remain the main barriers to adoption.

  3 papers · 30%

• Shared Neurodegeneration Biology

  Neurodegeneration research is moving toward cross-disease biology rather than isolated disease categories. Prospective cohorts seek shared risk patterns across Alzheimer's disease, amyotrophic lateral sclerosis and related disorders. Cross-disease microglial transcriptional programs identify SPP1 as a candidate biomarker. The open question is whether such signatures improve early detection or reveal therapeutically shared mechanisms.

  2 papers · 20%